Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Classifica tra le azioni #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Prezzo delle azioni
$137.21
Capitalizzazione di mercato
$170.34B
Variazione (1 giorno)
-2.76%
Variazione (1 anno)
28.14%
Paese
US
Scambia Gilead Sciences, Inc. (GILD)

Categoria

EPS per Gilead Sciences, Inc. (GILD)
EPS al December 2025 TTM: $6.85
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Gilead Sciences, Inc., l’EPS attuale della società (TTM) è $6.85. Alla fine del 2024, la società aveva un EPS di $0.38 una diminuzione rispetto a rispetto a quello del 2023, che era di $4.54.
Storico EPS per Gilead Sciences, Inc. da 2000 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $6.85 0.15%
2025 $6.84 1,700.00%
2024 $0.38 -91.63%
2023 $4.54 24.04%
2022 $3.66 -26.21%
2021 $4.96 4,966.39%
2020 $0.10 -97.69%
2019 $4.24 0.95%
2018 $4.20 18.64%
2017 $3.54 -64.88%
2016 $10.08 -18.51%
2015 $12.37 55.60%
2014 $7.95 295.52%
2013 $2.01 17.54%
2012 $1.71 -5.52%
2011 $1.81 6.47%
2010 $1.70 16.44%
2009 $1.46 33.94%
2008 $1.09 25.29%
2007 $0.87 -233.85%
2006 $-0.65 -244.44%
2005 $0.45 73.08%
2004 $0.26 -680.36%
2003 $-0.04 -196.76%
2002 $0.05 32.29%
2001 $0.04 -189.74%
2000 $-0.04 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$23.00 235.77%
US
$13.20 92.70%
GB
$11.10 62.04%
US
$2.37 -65.40%
US
$7.20 5.11%
CH